EX-23.2 3 s-8equityplanexhibit232.htm EXHIBIT 23.2 Exhibit


Exhibit 23.2



CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


We have issued our report dated March 22, 2018 with respect to the consolidated financial statements of Caladrius Biosciences, Inc. included in the Annual Report on Form 10-K for the year ended December 31, 2017, which are incorporated by reference in this Registration Statement. We consent to the incorporation by reference of the aforementioned report in this Registration Statement.


/s/GRANT THORNTON LLP

New York, New York
June 20, 2018